Perrigo Company plc Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent
Perrigo Company plc (PRGO) reported Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent of 100.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsDividends · last filed 2021-03-01
- Perrigo Company plc effective income tax rate reconciliation, deduction, dividend, percent for fiscal 2020 was 100.00%, a 0.00% change from fiscal 2019.
- Perrigo Company plc effective income tax rate reconciliation, deduction, dividend, percent for fiscal 2019 was 100.00%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent 12 month |
|---|---|
| 2020-12-31 | 100.00% 10-K · filed 2021-03-01 |
| 2019-12-31 | 100.00% 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |